Recent Patents On Anti-cancer Drug Discovery

杂志介绍

Recent Patents On Anti-cancer Drug Discovery杂志介绍

《Recent Patents On Anti-cancer Drug Discovery》是一本以English为主的未开放获取国际优秀期刊，中文名称最近的抗癌药物发现专利，本刊主要出版、报道医学-ONCOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为2.5，最新CiteScore 指数为4.5。

本刊近期中国学者发表的论文主要有：

• High-throughput Strategy Accelerates the Progress of Marine Anticancer Peptide Drug Development.

  Author: Lyu P¹, Kwok HF¹.

• Chimeric Antigen Receptor T Cell Immunotherapy for Tumor: A Review of Patent Literatures

  Author: Fu M¹, Tang L¹.

• From Antimicrobial to Anticancer Peptides: The Transformation of Peptides.

  Author: Qin Y^1,2, Qin ZD¹, Chen J³, Cai CG⁴, Li L¹, Feng LY¹, Wang Z¹, Duns GJ¹, He NY², Chen ZS⁵, Luo XF¹.

• Enzyme and Transporter Kinetics for CPT-11 (Irinotecan) and SN-38: An Insight on Tumor Tissue Compartment Pharmacokinetics Using PBPK.

  Author: Fan Y^1,2, Mansoor N³, Ahmad T⁴, Wu ZX², Khan RA³, Czejka M⁵, Sharib S⁴, Ahmed M⁶, Chen ZS², Yang DH².

英文介绍

Recent Patents On Anti-cancer Drug Discovery杂志英文介绍

Aims & Scope

Recent Patents on Anti-Cancer Drug Discovery publishes review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.